Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: The Diabetes Prevention Program outcomes study

Quality of Life Research

Volumn 23, Issue 1, 2014, Pages 75-88

  Marrero, D ^a,b   Pan, Q ^b   Barrett Connor, E ^c   De Groot, M ^a   Zhang, P ^d   Percy, C ^e   Florez, H ^f   Ackermann, R ^g   Montez, M ^h   Rubin, R R ⁱ  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Northern Navajo Medical Center   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis of diabetes; Health related quality of life; Pre diabetes; Prevention; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN; PLACEBO;

ARTICLE; BODY MASS; BODY WEIGHT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PROGRAM EVALUATION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SICKNESS IMPACT PROFILE; SOCIOECONOMICS; TREATMENT OUTCOME;

BODY MASS INDEX; BODY WEIGHT; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; LIFE STYLE; MALE; METFORMIN; MIDDLE AGED; PLACEBOS; PROGRAM EVALUATION; QUALITY OF LIFE; QUESTIONNAIRES; RISK REDUCTION BEHAVIOR; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84895062625     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0436-3     Document Type: Article

References (34)

1. Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related quality of life. Annals of Internal Medicine, 118(8), 622-629. (Pubitemid 23102698)
2. Garratt, A., Schmidt, L., Mackintosh, A., & Fitzpatrick, R. (2002). Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ, 324(1417), 1.
3. Rodger, A. J., Jolley, D., Thompson, S. C., Lanigan, A., & Crofts, N. (1999). The impact of diagnosis of hepatitis c virus on quality of life. Hepatology, 30(5), 1299-1301. (Pubitemid 29510870)
4. Ketelaars, C. A., Schlösser, M. A., Mostert, R., Huyer, A.-S. H., Halfens, R. J., & Wouters, E. F. (1996). Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax, 51, 39-43. (Pubitemid 26048724)
5. Sprangers, M. A. G., de Regt, E. B., Andries, F., van Agt, H. M., Bijl, R. V., de Boer, J. B., et al. (2000). Which chronic conditions are associated with better or poorer quality of life? Journal of Clinical Epidemiology, 53(9), 895-907.
6. Edelman, D., Olsen, M. K., Dudley, T. K., Harris, A. C., & Oddone, E. Z. (2002). Impact of diabetes screening on quality of life. Diabetes Care, 25(6), 1022-1102. (Pubitemid 41110488)
7. Biondi, B., Palmieri, E. A., Fazio, S., Cosco, C., Nocera, M., Sacca, L., et al. (2000). Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 4701-4705. (Pubitemid 32157655)
8. Helfand, M., & Redfern, C. C. (1998). Clinical guideline, part 2. Screening for thyroid disease: an update. Annals of Internal Medicine, 129, 144-158. (Pubitemid 28337261)
9. Jaeschke, R., Guyatt, G., Gerstein, H., Patterson, C., Molloy, W., Cook, D., et al. (1996). Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? Journal of General Internal Medicine, 11, 744-749. (Pubitemid 27009653)
10. Adriaanse, M. C., & Snoek, F. J. (2006). The psychological impact of screening for type 2 diabetes. Diabetes/Metabolism Research and Reviews, 22, 20-25. (Pubitemid 43154457)
11. Adriaanse, M. C., Dekker, J. M., Spijkerman, A. M. W., Twisk, J. W. R., Nijpels, G., van der Ploeg, H. M., et al. (2004). Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabetic Medicine, 21, 1075-1081. (Pubitemid 39389218)
12. Adriaanse, M. C., Snoek, F. J., Decker, J. M., et al. (2003). Perceived risk for type 2 diabetes in participants in a stepwise population screening programme. Diabetic Medicine, 20, 210-215. (Pubitemid 36390736)
13. Jackson, D. M., Wills, R., Davies, J., Meadows, K., Singh, B. M., & Wise, P. H. (1991). Public awareness of the symptoms of diabetes mellitus. Diabetic Medicine, 8, 971-972.
14. Farmer, A. J., Levy, J. C., & Turner, R. C. (1999). Knowledge of risk of developing diabetes mellitus among siblings of type 2 patients. Diabetic Medicine, 16, 233-237.
15. Adriaanse, M. C., Dekker, J. M., Spikerman, A. M. W., Twisk, J. W. R., Nijpels, G., van der Ploeg, H. M., et al. (2004). Health-related quality of life in the first year following diagnosis of type 2 diabetes: newly diagnosed patients in general practice compared with screening-detected patients. The Hoorn Screening Study. Diabetic Medicine, 21(10), 1075-1081. (Pubitemid 39389218)
16. The Diabetes Prevention Program Research Group. (1999). The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care, 22, 623-634.
17. The Diabetes Prevention Program Research Group. (2002). The Diabetes Prevention Program: recruitment methods and results. Controlled Clinical Trials, 23, 157-171. (Pubitemid 34273848)
18. The Diabetes Prevention Program Research Group. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346, 393-403. (Pubitemid 34437694)
19. The Diabetes Prevention Program Research Group. (2000). The Diabetes Prevention Program: Baseline characteristics of the randomized cohort. Diabetes Care, 23, 1619-1629.
20. The Diabetes Prevention Program (DPP) Research Group. (2002). The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care, 25, 623-634.
21. McHorney, C. A., Ware, J. E., & Raczek, A. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31(3), 247-263.
22. Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6D across seven patient groups. Health Economics, 13, 873-884. (Pubitemid 39264234)
23. Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for the two health state utility measures: EQ-5D and SF-6D. Quality of Life Research, 14(6), 1523-1532. (Pubitemid 40848233)
24. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
25. Fine, J. T., Colditz, G. A., Coakley, E. H., Moseley, G., Manson, J. E., Willett, W. C., et al. (1999). A prospective study of weight change and health-related quality of life in women. The Journal of the American Medical Association, 282, 2136-2142.
26. Kazis, L. E., Miller, D. R., Clark, J., Skinner, K., Lee, A., Rogers, W., et al. (1998). Health-related quality of life in patients served by the Department of Veterans Affairs: Results From the Veterans Health Study. Annals of Internal Medicine, 158(6), 626-632. (Pubitemid 28144820)
27. Kriska, A.M., Caspersen, C.J. (1997). Introduction to the collection of physical activity questionnaires in a collection of physical activity questionnaires for health-related research. In: Kriska, A.M., Caspersen, C.J. (Eds.), Centers for Disease Control and Prevention. Medicine and Science in Sports and Exercise, 29(Supp), S5-S9.
28. Curran, P. J., Obeidat, K., & Losardo, D. (2010). Twelve frequently asked questions about growth curve modeling. Journal of Cognition and Development, 11(2), 121-136.
29. Verbeke, G., & Molenberghs, G. (2009). Linear mixed models for longitudinal data. New York: Springer.
30. Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395-404. (Pubitemid 33081994)
31. Simon, G. E., Revicki, D. A., Grothaus, L., & Vonkorff, M. (1998). SF-36 summary scores: Are physical and mental health truly distinct? Medical Care, 36(4), 567-572. (Pubitemid 128452883)
32. Tuna, H. D., Edeer, A. O., Malkoc, M., & Aksakoglu, G. (2009). Effects of age and physical activity level on functional fitness in older adults. European Review of Aging and Physical Activity, 6(2), 99-106.
33. Ware, J. E., Kosinski, M., & Keller, S. D. (1994). SF-36 physical and mental health summary scales: A user's manual. Boston: The Health Institute, New England Medical Center.
34. Hopman, W. M., Berger, C., Joseph, L., Towheed, T., VandenKerkhof, E., Anastassiades, T., et al. (2006). The natural progression of health related quality of life: Results of a five-year prospective study of the SF-36 scores in a normative population. Quality of Life Research, 15, 527-536.